Discontinuation report CLAFORAN - PWS INJ 2.0G/VIAL
| Report ID | 3685 |
| Drug Identification Number | 02225107 |
| Brand name | CLAFORAN - PWS INJ 2.0G/VIAL |
| Common or Proper name | CLAFORAN 2G X 10 VIALS |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFOTAXIME SODIUM |
| Strength(s) | 2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 VIALS |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-03-31 |
| Actual discontinuation date | 2017-04-04 |
| Remaining supply date | 2017-03-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Distribution of remaining inventory up to one month prior to product expiry |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-04-05 | English | Compare |
| v4 | 2017-04-04 | French | Compare |
| v3 | 2017-04-04 | English | Compare |
| v2 | 2017-03-20 | French | Compare |
| v1 | 2017-03-20 | English | Compare |
Showing 1 to 5 of 5